MedTrace Logo

Beta-glucan Effects on Lipid Profile, Glycemia and inTestinal Health (BELT)

NCT03313713 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 85

Last updated 2017-10-19

No results posted yet for this study

Summary

This will be a randomized, placebo-controlled, clinical trial carried out on moderately hypercholesterolemic subjects who will consume 3 g per day of beta-glucans, in order to evaluate the effects on lipid profile, glycemia and intestinal function

Conditions

Interventions

DIETARY_SUPPLEMENT

Beta-glucans

Placebo consumption at breakfast (3 g per day)

DIETARY_SUPPLEMENT

Placebo

Placebo consumption at breakfast (3 g per day)

Sponsors & Collaborators

  • University of Bologna

    lead OTHER

Principal Investigators

  • Claudio Borghi, MD · S. Orsola-Malpighi University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-26
Primary Completion
2017-12-31
Completion
2018-03-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03313713 on ClinicalTrials.gov